The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Relationship between pre-treatment organ-specific tumor burden (TB) and response to immunotherapy in advanced melanoma (MEL).
 
Ryan Campbell Massa
No Relationships to Disclose
 
Mark Sparrow
No Relationships to Disclose
 
Huang Lin
No Relationships to Disclose
 
Yan Lin
No Relationships to Disclose
 
David J. Mauro
Employment - Checkmate Pharmaceuticals
Leadership - Checkmate Pharmaceuticals
Stock and Other Ownership Interests - Checkmate Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Checkmate Pharmaceuticals
 
Art M. Krieg
Employment - Checkmate Pharmaceuticals
Leadership - Checkmate Pharmaceuticals
Stock and Other Ownership Interests - Checkmate Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Checkmate Pharmaceuticals
 
Heather Kelley
Employment - Checkmate Pharmaceuticals
Stock and Other Ownership Interests - Checkmate Pharmaceuticals
Consulting or Advisory Role - Checkmate Pharmaceuticals
 
Amy Rose
No Relationships to Disclose
 
Yana G. Najjar
Research Funding - Merck
 
John M. Kirkwood
Consulting or Advisory Role - Amgen; Array BioPharma; Bristol-Myers Squibb; Immunocore; Merck; Novartis; Roche
Research Funding - Merck (Inst); Prometheus (Inst)
 
Diwakar Davar
Consulting or Advisory Role - Incyte; Merck
Research Funding - Bristol-Myers Squibb; Checkmate Pharmaceuticals; Incyte; Merck